Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

14 Result(s)

2 Expert centre networks ; 7 Research project networks ; 4 Multinational clinical trials ; 1 Biobank networks ;

    Expert centre networks

    • GERMANY
    • Berlin
    • BERLIN
    • Competence Network Paediatric Oncology and Haematology (Expert centres)
    • Charité - Universitätsmedizin Berlin (CVK)
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • ENERCA - European network of expert centres for rare and congenital anaemias
    • Hospital Clínic de Barcelona
    • More information

    • Research project networks

    • AUSTRIA
    • TIROL
    • INNSBRUCK
    • HUS: European study group on Hemolytic Uremic Syndrome
    • Medizinische Universität Innsbruck
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUSSELS
    • EUNEFRON: the European network for the study of orphan nephropathies
    • Cliniques Universitaires UCL de Saint Luc - UCLStLuc
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Groupe d'étude de microangiopathies thrombotiques
    • CHU Paris Est - Hôpital Saint-Antoine
    • More information
    • ITALY
    • LOMBARDIA
    • BERGAMO
    • PRATH: preclinical study of recombinant human anti-C5 for the treatment of atypical hemolytic uremic syndrome
    • ADIENNE S.R.L.
    • More information
    • NETHERLANDS
    • Gelderland
    • NIJMEGEN
    • IGMD - Institute for Genetic and Metabolic Disease
    • UMC St Radboud - Universitair Medisch Centrum St Radboud
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • ENERCA: European network for rare and congenital anaemias
    • Hospital Clínic de Barcelona
    • More information
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • European Paediatric Research for Hemolytic Uremic Syndrome (HUS)
    • Birmingham Children's Hospital
    • More information

    • Multinational clinical trials

    • UNITED STATES
    • Connecticut
    • CHESHIRE
    • An open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) (coordination)
    • Alexion Pharmaceuticals, Inc.
    • More information
    • UNITED STATES
    • Connecticut
    • CHESHIRE
    • An open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) (coordination)
    • Alexion Pharmaceuticals, Inc.
    • More information
    • UNITED STATES
    • Connecticut
    • CHESHIRE
    • An open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) (coordination)
    • Alexion Pharmaceuticals, Inc.
    • More information
    • UNITED STATES
    • Connecticut
    • CHESHIRE
    • An open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) (coordination)
    • Alexion Pharmaceuticals, Inc.
    • More information

    • Biobank networks

    • ITALY
    • LIGURIA
    • GENOVA
    • TELETHON NETWORK OF GENETIC BIOBANKS
    • IRCCS Istituto G. Gaslini - Ospedale Pediatrico
    • More information